Haier BioMedical Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
2,945
- Stock Symbol
-
688139
- Investments
-
15
- Share Price
-
$4.47
- (As of Friday Closing)
Haier BioMedical General Information
Description
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing, and sales of low-temperature storage equipment for biomedical samples. The company provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies, and reagent safety.
Contact Information
Website
www.haiermedical.comCorporate Office
- No. 280 Feng Yuan Road
- High-tech Zone, Qingdao
- Qingdao, Shandong 266109
- China
Corporate Office
- No. 280 Feng Yuan Road
- High-tech Zone, Qingdao
- Qingdao, Shandong 266109
- China
Haier BioMedical Stock Performance
As of 20-Nov-2026, Haier BioMedical’s stock price is $4.47. Its current market cap is $1.41B with 316M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.47 | $4.55 | $3.59 - $5.59 | $1.41B | 316M | 3.86M | $0.13 |
Haier BioMedical Financials Summary
As of 30-Sep-2026, Haier BioMedical has a trailing 12-month revenue of $367M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,512,101 | 1,293,119 | 1,318,759 | 1,548,292 |
| Revenue | 367,266 | 323,817 | 318,284 | 322,394 |
| EBITDA | 38,084 | 49,899 | 66,649 | 71,497 |
| Net Income | 39,469 | 34,866 | 51,095 | 57,397 |
| Total Assets | 888,293 | 827,749 | 792,793 | 779,517 |
| Total Debt | 13,286 | 13,599 | 4,198 | 4,161 |
Haier BioMedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Haier BioMedical Signals
Haier BioMedical Investments & Acquisitions (15)
Haier BioMedical’s most recent deal was a Merger/Acquisition with Metash. The deal was made on 23-May-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Metash | 23-May-2024 | Merger/Acquisition | Other Devices and Supplies | ||
| Chaolian Technology (Electrical Equipment) | 16-Jun-2023 | Merger/Acquisition | Electrical Equipment | ||
| Haier Biomedical (Medical Supplies) | 03-Apr-2023 | Merger/Acquisition | Medical Supplies | ||
| Suzhou Kangsheng | 02-Dec-2022 | Merger/Acquisition | Medical Supplies | ||
| Jinweixin | 27-Oct-2022 | Merger/Acquisition | Other Healthcare Technology Systems |
Haier BioMedical ESG
Risk Overview
Risk Rating
Updated November, 30, 2024
17.91 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,999
Rank
Percentile
Pharmaceuticals
Industry
of 952
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 70
Rank
Percentile
Haier BioMedical Exits (1)
Haier BioMedical’s most recent exit was on 04-Jan-2016 from Labtech International. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Labtech International | 04-Jan-2016 | Completed |
|
Haier BioMedical Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Suzhou Kangsheng | Suzhou, China | 2020 | |
| Chaolian Technology (Electrical Equipment) | Shanghai, China | 2020 | |
| Haier Biomedical (Medical Supplies) | Suzhou, China | 2015 | |
| Metash | Shanghai, China | 2008 | |
| Chongqing Sandaweiye | Chongqing, China | 2001 |
Haier BioMedical FAQs
-
When was Haier BioMedical founded?
Haier BioMedical was founded in 1998.
-
Where is Haier BioMedical headquartered?
Haier BioMedical is headquartered in Qingdao, China.
-
What is the size of Haier BioMedical?
Haier BioMedical has 2,945 total employees.
-
What industry is Haier BioMedical in?
Haier BioMedical’s primary industry is Medical Supplies.
-
Is Haier BioMedical a private or public company?
Haier BioMedical is a Public company.
-
What is Haier BioMedical’s stock symbol?
The ticker symbol for Haier BioMedical is 688139.
-
What is the current stock price of Haier BioMedical?
As of 20-Nov-2026 the stock price of Haier BioMedical is $4.47.
-
What is the current market cap of Haier BioMedical?
The current market capitalization of Haier BioMedical is $1.41B.
-
What is Haier BioMedical’s current revenue?
The trailing twelve month revenue for Haier BioMedical is $367M.
-
What is Haier BioMedical’s annual earnings per share (EPS)?
Haier BioMedical’s EPS for 12 months was $0.13.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process